First Time Loading...
C

Carasent ASA
OSE:CARA

Watchlist Manager
Carasent ASA
OSE:CARA
Watchlist
Price: 18.75 NOK 0.27% Market Closed
Updated: May 15, 2024

Intrinsic Value

Carasent ASA is an investment management company, which in the development of entrepreneurial and e-health solutions. [ Read More ]

The intrinsic value of one CARA stock under the Base Case scenario is 15.48 NOK. Compared to the current market price of 18.75 NOK, Carasent ASA is Overvalued by 17%.

Key Points:
CARA Intrinsic Value
Base Case
15.48 NOK
Overvaluation 17%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation Backtest
Carasent ASA

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling CARA stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Carasent ASA

Provide an overview of the primary business activities
of Carasent ASA.

What unique competitive advantages
does Carasent ASA hold over its rivals?

What risks and challenges
does Carasent ASA face in the near future?

Summarize the latest earnings call
of Carasent ASA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Carasent ASA.

Provide P/S
for Carasent ASA.

Provide P/E
for Carasent ASA.

Provide P/OCF
for Carasent ASA.

Provide P/FCFE
for Carasent ASA.

Provide P/B
for Carasent ASA.

Provide EV/S
for Carasent ASA.

Provide EV/GP
for Carasent ASA.

Provide EV/EBITDA
for Carasent ASA.

Provide EV/EBIT
for Carasent ASA.

Provide EV/OCF
for Carasent ASA.

Provide EV/FCFF
for Carasent ASA.

Provide EV/IC
for Carasent ASA.

Show me price targets
for Carasent ASA made by professional analysts.

What are the Revenue projections
for Carasent ASA?

How accurate were the past Revenue estimates
for Carasent ASA?

What are the Net Income projections
for Carasent ASA?

How accurate were the past Net Income estimates
for Carasent ASA?

What are the EPS projections
for Carasent ASA?

How accurate were the past EPS estimates
for Carasent ASA?

What are the EBIT projections
for Carasent ASA?

How accurate were the past EBIT estimates
for Carasent ASA?

Compare the revenue forecasts
for Carasent ASA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Carasent ASA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Carasent ASA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Carasent ASA compared to its peers.

Compare the P/E ratios
of Carasent ASA against its peers.

Discuss the investment returns and shareholder value creation
comparing Carasent ASA with its peers.

Analyze the financial leverage
of Carasent ASA compared to its main competitors.

Show all profitability ratios
for Carasent ASA.

Provide ROE
for Carasent ASA.

Provide ROA
for Carasent ASA.

Provide ROIC
for Carasent ASA.

Provide ROCE
for Carasent ASA.

Provide Gross Margin
for Carasent ASA.

Provide Operating Margin
for Carasent ASA.

Provide Net Margin
for Carasent ASA.

Provide FCF Margin
for Carasent ASA.

Show all solvency ratios
for Carasent ASA.

Provide D/E Ratio
for Carasent ASA.

Provide D/A Ratio
for Carasent ASA.

Provide Interest Coverage Ratio
for Carasent ASA.

Provide Altman Z-Score Ratio
for Carasent ASA.

Provide Quick Ratio
for Carasent ASA.

Provide Current Ratio
for Carasent ASA.

Provide Cash Ratio
for Carasent ASA.

What is the historical Revenue growth
over the last 5 years for Carasent ASA?

What is the historical Net Income growth
over the last 5 years for Carasent ASA?

What is the current Free Cash Flow
of Carasent ASA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Carasent ASA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Carasent ASA

Current Assets 446.2m
Cash & Short-Term Investments 373.9m
Receivables 65m
Other Current Assets 7.3m
Non-Current Assets 660.9m
PP&E 50m
Intangibles 610.9m
Other Non-Current Assets -1k
Current Liabilities 115.2m
Accounts Payable 19.2m
Accrued Liabilities 33.7m
Other Current Liabilities 62.3m
Non-Current Liabilities 47m
Long-Term Debt 37.1m
Other Non-Current Liabilities 9.9m
Efficiency

Earnings Waterfall
Carasent ASA

Revenue
250.9m NOK
Cost of Revenue
-45.1m NOK
Gross Profit
205.9m NOK
Operating Expenses
-241.8m NOK
Operating Income
-35.9m NOK
Other Expenses
-20m NOK
Net Income
-56m NOK

Free Cash Flow Analysis
Carasent ASA

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

CARA Profitability Score
Profitability Due Diligence

Carasent ASA's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
ROE is Increasing
Positive Revenue Growth Forecast
42/100
Profitability
Score

Carasent ASA's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

CARA Solvency Score
Solvency Due Diligence

Carasent ASA's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Negative Net Debt
Low D/E
Short-Term Solvency
67/100
Solvency
Score

Carasent ASA's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CARA Price Targets Summary
Carasent ASA

Wall Street analysts forecast CARA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CARA is 26.27 NOK with a low forecast of 25.25 NOK and a high forecast of 27.83 NOK.

Lowest
Price Target
25.25 NOK
35% Upside
Average
Price Target
26.27 NOK
40% Upside
Highest
Price Target
27.83 NOK
48% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

CARA Price
Carasent ASA

1M 1M
+71%
6M 6M
+61%
1Y 1Y
+35%
3Y 3Y
-45%
5Y 5Y
+247%
10Y 10Y
+27%
Annual Price Range
18.75
52w Low
10.1
52w High
18.95
Price Metrics
Average Annual Return 74.21%
Standard Deviation of Annual Returns 138.19%
Max Drawdown -80%
Shares Statistics
Market Capitalization 1.4B NOK
Shares Outstanding 72 324 781
Percentage of Shares Shorted
N/A

CARA Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Carasent ASA

Country

Norway

Industry

Health Care

Market Cap

1.4B NOK

Dividend Yield

9.81%

Description

Carasent ASA is an investment management company, which in the development of entrepreneurial and e-health solutions. The company is headquartered in Oslo, Oslo. The company went IPO on 2002-04-08. The company operates through its subsidiary Evimeria EMR AB, which offers digital eHealth services primarily at specialist care, primary care and paramedics. The firm provides Webdoc, a Web-based care management system for health professionals that reduces the risk of resource-intensive routines. The system is customizable and also offers integration solutions. The firm is active in the Nordic region.

Contact

OSLO
Oslo
Ovre Slottsgate 2B
+46733550935.0
https://carasent.com/

IPO

2002-04-08

Employees

-

Officers

Founder,Chief Product Officer & Business Developer
Mr. Niclas Hugosson
Chief Financial Officer
Mr. Svein Martin Bjornstad
Chief Executive Officer
Mr. Daniel Ohman
Chief Technical Officer
Johan Eltes
Legal Counsel
Advocate Jon Schultz
Chief Compliance Officer
Stefan Jernberg
Show More
Vice President of Sales & Business Development
Mr. Chris Damvakaris
Chief Marketing Officer
Cornelia Broqvist
People and Culture Manager
Anna Holmen Larsson
Head of Strategy
Vilma Jonson
Show Less

See Also

Discover More
What is the Intrinsic Value of one CARA stock?

The intrinsic value of one CARA stock under the Base Case scenario is 15.48 NOK.

Is CARA stock undervalued or overvalued?

Compared to the current market price of 18.75 NOK, Carasent ASA is Overvalued by 17%.